There are numerous regulations at both the state and federal level, which govern the purchase of, access to and use of controlled substances. The OACIB in conjunction with the Biologic Resources Laboratory, and the UIC Ambulatory Care Pharmacy is responsible for oversight of the program at UIC that regulates controlled substance use in animal research.

The goal of the OACIB is to facilitate the process for the investigator and to ensure compliance of with federal and state regulations.

Please contact us if you have any questions regarding the use of controlled substances in animal research.

CS Announcements

Grants and Contracts Sponsored Program Expenditures Reports Available

Dec 11

This announcement applies to Chicago only.

The UIC Office of Grants and Contracts has published the “Analysis of Sponsored Program Expenditures for Fiscal Years 2013 – 2017” on the OBFS website.

While the overall reporting format has not changed, the OVCR Grants and Contracts Office has published this report in both PDF and Excel formats to facilitate further analysis by units.

2017 OVCR Holiday Schedules

Nov 7

Office of Research Services (ORS) 2017 Holiday Schedule

The Office of Research Services (ORS) will observe the UIC reduced service schedule for non-essential services that begins on Monday, December 25th. As such, ORS will close at 5:00 PM on Friday, December 22, 2017, and will reopen at 8:30 AM on Tuesday, January 2, 2018.

To ensure timely review and processing of sponsored project activities - applications and related documents due prior to Tuesday, January 2, 2018 - please be advised of the following internal deadlines:

Open Membership Research Workshops

Apr 5

Dear Colleagues,

The Office of the Vice Chancellor for Research invites you to participate in our open membership research workshops related to the UIC “Research Strengths and Themes” that will help develop the areas or subareas of UIC faculty research in emerging funding opportunities.

MTEC Funding Opportunities for Faculty

Mar 10

UIC is a member of the Medical Technology Enterprise Consortium (MTEC).  This relatively new enterprise will provide funding opportunities in the following areas of research that may be of interest: